文献速递肾移植

血清和尿液细胞外囊泡特征可预测肾移植后肾脏结局的鉴定

Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant.
PubMed 文献 · Nephrol Dial Transplant · 2023-01-01

该研究对58例肾移植患者移植前及移植后10-14天、3个月和1年的血清和尿液细胞外囊泡进行37种表面抗原流式分析,共426份样本。结果显示血清EV内皮和血小板标志物在1年持续肾功能不全患者基线较高,尿液EV间充质祖细胞标志物在肾功能恢复患者移植后逐渐升高,且基于监督学习构建的EV分子特征能正确分类1年肾脏结局。

要点

  • 血清EV内皮和血小板标志物(CD31、CD41b、CD42a、CD62P)在1年持续肾功能不全患者基线较高。
  • 尿液EV间充质祖细胞标志物(CD1c、CD105、CD133、SSEEA-4)在肾功能恢复患者移植后逐渐升高。
  • EV标志物与eGFR、肌酐和蛋白尿相关,并在ROC曲线分析中能预测患者结局。

核心结论

  • 反映受者心血管特征和移植物修复/再生特征的EV特征可作为无创工具用于肾移植患者随访的个体化管理。

研究设计与样本

  • 研究纳入58例肾移植患者,在移植前及移植后10-14天、3个月和1年评估血清和尿液细胞外囊泡,共分析426份样本。
  • 通过流式细胞术检测37种表面抗原,结局根据1年时估算肾小球滤过率(eGFR)定义。

主要发现

  • 血清EV中内皮细胞和血小板标志物(CD31、CD41b、CD42a和CD62P)在1年持续肾功能不全患者基线较高,并在肾移植后逐渐下降。
  • 尿液EV中间充质祖细胞标志物(CD1c、CD105、CD133、SSEEA-4)在随访显示肾功能恢复的患者移植后逐渐升高。
  • 这些标志物与eGFR、肌酐和蛋白尿相关,在单变量分析中与患者结局相关,并在受试者工作特征曲线分析中能预测患者结局。
  • 通过监督学习获得的特定EV分子特征能根据1年肾脏结局正确分类患者。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A long-standing effort is dedicated towards the identification of biomarkers allowing the prediction of graft outcome after kidney transplant. Extracellular vesicles (EVs) circulating in body fluids represent an attractive candidate, as their cargo mirrors the originating cell and its pathophysiological status. The aim of the study was to investigate EV surface antigens as potential predictors of renal outcome after kidney transplant. METHODS: We characterized 37 surface antigens by flow cytometry, in serum and urine EVs from 58 patients who were evaluated before, and at 10-14 days, 3 months and 1 year after transplant, for a total of 426 analyzed samples. The outcome was defined according to estimated glomerular filtration rate (eGFR) at 1 year. RESULTS: Endothelial cells and platelets markers (CD31, CD41b, CD42a and CD62P) in serum EVs were higher at baseline in patients with persistent kidney dysfunction at 1 year, and progressively decreased after kidney transplant. Conversely, mesenchymal progenitor cell marker (CD1c, CD105, CD133, SSEEA-4) in urine EVs progressively increased after transplant in patients displaying renal recovery at follow-up. These markers correlated with eGFR, creatinine and proteinuria, associated with patient outcome at univariate analysis and were able to predict patient outcome at receiver operating characteristics curves analysis. A specific EV molecular signature obtained by supervised learning correctly classified patients according to 1-year renal outcome. CONCLUSIONS: An EV-based signature, reflecting the cardiovascular profile of the recipient, and the repairing/regenerative features of the graft, could be introduced as a non-invasive tool for a tailored management of follow-up of patients undergoing kidney transplant.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Burrello J, Monticone S, Burrello A, et al. Identification of a serum and urine extracellular vesicle signature predicting renal outcome after kidney transplant. Nephrol Dial Transplant. 2023. PMID: 36073758. doi:10.1093/ndt/gfac259

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。